JP2001178486A - Method for producing polyhydroxyalkanoate - Google Patents
Method for producing polyhydroxyalkanoateInfo
- Publication number
- JP2001178486A JP2001178486A JP37187099A JP37187099A JP2001178486A JP 2001178486 A JP2001178486 A JP 2001178486A JP 37187099 A JP37187099 A JP 37187099A JP 37187099 A JP37187099 A JP 37187099A JP 2001178486 A JP2001178486 A JP 2001178486A
- Authority
- JP
- Japan
- Prior art keywords
- pha
- microorganism
- polyhydroxyalkanoate
- medium
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 title claims abstract description 60
- 229920000903 polyhydroxyalkanoate Polymers 0.000 title claims abstract description 59
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 20
- 239000000178 monomer Substances 0.000 claims abstract description 21
- JTXZPQIXIXYMDY-UHFFFAOYSA-N 6-phenylhexanoic acid Chemical compound OC(=O)CCCCCC1=CC=CC=C1 JTXZPQIXIXYMDY-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000126 substance Substances 0.000 claims abstract description 7
- 238000012258 culturing Methods 0.000 claims description 12
- 241000589516 Pseudomonas Species 0.000 claims description 8
- 241001300822 Pseudomonas jessenii Species 0.000 claims description 7
- 244000005700 microbiome Species 0.000 abstract description 46
- LIEBCJFOQCWDHJ-UHFFFAOYSA-N 3-hydroxy-6-phenylhexanoic acid Chemical compound OC(=O)CC(O)CCCC1=CC=CC=C1 LIEBCJFOQCWDHJ-UHFFFAOYSA-N 0.000 abstract description 16
- 125000001424 substituent group Chemical group 0.000 abstract description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract description 5
- 230000000813 microbial effect Effects 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract 2
- 239000001963 growth medium Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 229940041514 candida albicans extract Drugs 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 239000012138 yeast extract Substances 0.000 description 7
- REKYPYSUBKSCAT-UHFFFAOYSA-N 3-hydroxypentanoic acid Chemical compound CCC(O)CC(O)=O REKYPYSUBKSCAT-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 150000004667 medium chain fatty acids Chemical class 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- 230000005526 G1 to G0 transition Effects 0.000 description 3
- 241000589774 Pseudomonas sp. Species 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- PGIOANNVJQQCDT-UHFFFAOYSA-N 2-phenylhexanoic acid Chemical compound CCCCC(C(O)=O)C1=CC=CC=C1 PGIOANNVJQQCDT-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241001600125 Delftia acidovorans Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 241000589781 Pseudomonas oleovorans Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- -1 acyclic aliphatic hydrocarbon Chemical class 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229920001002 functional polymer Polymers 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- IMMRMPAXYUIDLR-UHFFFAOYSA-N (R)-3-Hydroxy-5-phenylpentanoic acid Chemical compound OC(=O)CC(O)CCC1=CC=CC=C1 IMMRMPAXYUIDLR-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HPMGFDVTYHWBAG-UHFFFAOYSA-N 3-hydroxyhexanoic acid Chemical compound CCCC(O)CC(O)=O HPMGFDVTYHWBAG-UHFFFAOYSA-N 0.000 description 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 1
- 229940006015 4-hydroxybutyric acid Drugs 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 241000607516 Aeromonas caviae Species 0.000 description 1
- 241000607519 Aeromonas sp. Species 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 108010082340 Arginine deiminase Proteins 0.000 description 1
- 101100316860 Autographa californica nuclear polyhedrosis virus DA18 gene Proteins 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 241001508395 Burkholderia sp. Species 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- 241001478312 Comamonas sp. Species 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000589309 Methylobacterium sp. Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000589598 Paracoccus sp. Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 208000037534 Progressive hemifacial atrophy Diseases 0.000 description 1
- DRUQKRWRXOUEGS-NGERZBJRSA-N Samin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3O)=C1 DRUQKRWRXOUEGS-NGERZBJRSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 150000008282 halocarbons Chemical group 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 238000010128 melt processing Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000006140 methanolysis reaction Methods 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 238000012017 passive hemagglutination assay Methods 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
Landscapes
- Polyesters Or Polycarbonates (AREA)
- Biological Depolymerization Polymers (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、新規なポリヒドロ
キシアルカノエート(PHA)およびその製造方法に関
する。より具体的には、本発明は、3−ヒドロキシ−6
−フェニルヘキサン酸をモノマーユニットとするポリヒ
ドロキシアルカノエート(PHA)を生産し菌体内に蓄
積する能力を有する微生物を用いて、係る微生物産生ポ
リヒドロキシアルカノエートを高い選択性で製造させる
方法に関する。The present invention relates to a novel polyhydroxyalkanoate (PHA) and a method for producing the same. More specifically, the present invention relates to 3-hydroxy-6
The present invention relates to a method for producing such a microbial polyhydroxyalkanoate with high selectivity using a microorganism capable of producing and accumulating polyhydroxyalkanoate (PHA) having phenylhexanoic acid as a monomer unit.
【0002】[0002]
【従来の技術】これまで、多くの微生物がポリ−3−ヒ
ドロキシ酪酸(PHB)あるいはその他のPHAを生産
し、菌体内に蓄積することが報告されてきた(「生分解
性プラスチックハンドブック」,生分解性プラスチック
研究会編,(株)エヌ・ティー・エス,P178−19
7)。これらの微生物産生ポリマーは、従来のプラスチ
ックと同様に、溶融加工等により各種製品の生産に利用
することができる。さらに、生分解性であるがゆえに、
自然界で微生物により完全分解されるという利点を有し
ている。従って、従来用いられている、多くの合成高分
子化合物のように自然環境に残留して汚染を引き起こす
ことがなく、また、燃焼処理を行う必要もないため、大
気汚染や地球温暖化の観点でも、なんらの懸念もない材
料となる。また、生体適合性にも優れており、医療用軟
質部材等としての応用も期待されている。2. Description of the Related Art It has been reported that many microorganisms produce poly-3-hydroxybutyric acid (PHB) or other PHA and accumulate in cells ("Biodegradable Plastic Handbook", Edible Plastics Study Group, NTT Corp., P178-19
7). These microorganism-producing polymers can be used for production of various products by melt processing or the like, similarly to conventional plastics. Furthermore, because it is biodegradable,
It has the advantage of being completely degraded by microorganisms in nature. Therefore, unlike conventional synthetic polymer compounds, they do not remain in the natural environment and cause pollution, and there is no need to perform combustion treatment. , A material without any concerns. It is also excellent in biocompatibility and is expected to be applied as a soft medical member.
【0003】微生物産生PHAは、その生産に用いる微
生物の種類や培地組成、培養条件等により、様々な組成
や構造のものとなり得ることが知られている。これまで
主に、PHAの物性の改良という観点から、微生物産生
PHAの組成や構造を制御する方法に関する研究がなさ
れてきた。[0003] It is known that microorganism-produced PHA can have various compositions and structures depending on the kind of microorganism used for its production, the composition of the medium, the culture conditions, and the like. Until now, mainly from the viewpoint of improving the physical properties of PHA, studies on methods for controlling the composition and structure of PHA produced by microorganisms have been made.
【0004】例えば、アルカリゲネス・ユウトロファス
H16株(Alcaligenes eutropusH16、ATCC No.17699)
ならびにその変異株は、培養時の炭素源を変化させるこ
とによって、3−ヒドロキシ酪酸(3HB)と3−ヒド
ロキシ吉草酸(3HV)との共重合体を様々な組成比で
生産することが報告されている(特表平6−15604
号公報、特表平7−14352号公報、特表平8−19
227号公報 等)。[0004] For example, Alcaligenes eutropus H16 (ATCC No.17699)
In addition, it has been reported that the mutants produce copolymers of 3-hydroxybutyric acid (3HB) and 3-hydroxyvaleric acid (3HV) at various composition ratios by changing the carbon source during culture. (Table 6-15604)
Gazette, Japanese Patent Publication No. Hei 7-14352, Japanese Patent Publication No. Hei 8-19
227, etc.).
【0005】また、特許第2642937号公報には、
シュードモナス・オレオボランス・ATCC29347
株(Pseudomonas oleovorans ATCC29347)に、炭素源と
して非環状脂肪族炭化水素を与えることにより、炭素数
が6〜12までの3−ヒドロキシアルカノエートをモノ
マーユニットとするPHAを生産することが開示されて
いる。Also, Japanese Patent No. 2642937 discloses that
Pseudomonas oreobolans ATCC 29347
It is disclosed that a strain (Pseudomonas oleovorans ATCC29347) is provided with an acyclic aliphatic hydrocarbon as a carbon source to produce PHA having a monomer unit of 3-hydroxyalkanoate having 6 to 12 carbon atoms. .
【0006】特開平5−74492号公報では、メチロ
バクテリウム属(Methylobacteriumsp.)、パラコッカ
ス属(Paracoccus sp.)、アルカリゲネス属(Alcalige
nessp.)、シュードモナス属(Pseudomonas sp.)の微
生物を、炭素数3〜7の第一級アルコールに接触させる
ことにより、3HBと3HVとの共重合体を生産させる
方法が開示されている。Japanese Patent Application Laid-Open No. 5-74492 discloses a genus Methylobacterium sp., A genus Paracoccus sp., And a genus Alcalige.
nessp.) and a method of producing a copolymer of 3HB and 3HV by contacting a microorganism of the genus Pseudomonas sp. with a primary alcohol having 3 to 7 carbon atoms.
【0007】特開平5−93049号公報および特開平
7−265065号公報では、アエロモナス・キャビエ
(Aeromonas caviae)を、オレイン酸やオリーブ油を炭
素源として培養することにより、3HBと3−ヒドロキ
シヘキサン酸(3HHx)の2成分共重合体を生産する
ことが開示されている。[0007] JP-A-5-93049 and JP-A-7-265065 disclose that 3HB and 3-hydroxyhexanoic acid (Aeromonas caviae) are cultured by using oleic acid or olive oil as a carbon source. 3HHx) is disclosed to produce a two-component copolymer.
【0008】特開平9−191893号公報では、コマ
モナス・アシドボランス・IFO13852株(Comamo
nas acidovorans IFO13852)は、炭素源としてグルコン
酸及び1,4−ブタンジオールを用いて培養すると、3
HBと4−ヒドロキシ酪酸とをモノマーユニットに持つ
ポリエステルを生産することが開示されている。Japanese Patent Application Laid-Open No. 9-191893 discloses that Comamonas acidovorans IFO13852 strain (Comamo
nas acidovorans IFO13852), when cultured using gluconic acid and 1,4-butanediol as carbon sources, 3
It is disclosed to produce a polyester having HB and 4-hydroxybutyric acid as monomer units.
【0009】さらに、ある種の微生物では、様々な置換
基、例えば、不飽和炭化水素基、エステル基、アリル
基、シアノ基、ハロゲン化炭化水素基、エポキシド等が
導入されたPHAを生産することが報告されており、こ
のような手法によって微生物産生PHAの物性改良を目
指す試みもなされ始めている。Further, some microorganisms produce PHA into which various substituents, for example, unsaturated hydrocarbon groups, ester groups, allyl groups, cyano groups, halogenated hydrocarbon groups, epoxides, etc. are introduced. And attempts have been made to improve the physical properties of microorganism-produced PHA by such techniques.
【0010】例えば、Makromol. Chem., 191, 1957-196
5,1990、Macromolecules, 24, 5256-5260,1991、Chiral
ity, 3, 492-494,1991 等では、シュードモナス・オレ
オボランスが3−ヒドロキシ−5−フェニル吉草酸(3
HPV)をモノマーユニットとして含むPHAを生産す
ることが報告されており、3HPVが含まれることに起
因すると思われる、ポリマー物性の変化が認められてい
る。For example, Makromol. Chem., 191, 1957-196
5,1990, Macromolecules, 24, 5256-5260,1991, Chiral
, 3, 492-494, 1991, etc., Pseudomonas oleovorans dissolves 3-hydroxy-5-phenylvaleric acid (3
It has been reported to produce PHA containing (HPV) as a monomer unit, and a change in polymer physical properties, which may be caused by the inclusion of 3HPV, has been observed.
【0011】[0011]
【発明が解決しようとする課題】以上に述べたように、
微生物産生PHAにおいて、その生産に用いる微生物の
種類や培地組成、培養条件等を変えることにより、何通
りかの組成・構造のものが得られているが、それらの試
みの主な目的は、専らPHAに含まれる複数のヒドロキ
シアルカン酸(HA)の比率を変え、プラスチックとし
ての物性の改良を図ることであった。As described above, as described above,
In microbial PHA, several types of compositions and structures have been obtained by changing the type of microorganism used, the medium composition, the culture conditions, etc., but the main purpose of these attempts is exclusively The purpose was to change the ratio of a plurality of hydroxyalkanoic acids (HA) contained in the PHA to improve the physical properties as a plastic.
【0012】一方、様々な置換基を導入したPHAは、
導入された置換基の特性等に起因する、極めて有用な機
能・特性を具備した「機能性ポリマー」としての展開も
期待できる。生分解性に加え、そのような機能性をも兼
ね備えた、新たなポリマーと、微生物を利用して、その
生産を行う方法、並びに当該ポリマーを生産し菌体内に
蓄積し得る微生物の開発、選別分離は、極めて有用かつ
重要であると考えられる。On the other hand, PHAs having various substituents introduced are
The development as a “functional polymer” having extremely useful functions and characteristics due to the characteristics of the introduced substituents can be expected. A new polymer that has such functionality in addition to biodegradability, a method for producing it using microorganisms, and the development and selection of microorganisms that can produce the polymer and accumulate in the cells Separation is considered extremely useful and important.
【0013】本発明は、前記の課題を解決するもので、
本発明の目的は、生分解性を示し、フェニル基を置換基
として有する新規なPHAの提供、ならびに、前記のフ
ェニル基を置換基として有するPHAを微生物を利用し
て製造する方法、その際利用する新規な微生物の提供す
ることにある。特には、3−ヒドロキシ−6−フェニル
−ヘキサン酸(3HPHx)を単一のモノマーユニット
とする新規なPHAと前記のフェニル基を置換基として
有するPHAを微生物を利用して製造する方法、その際
利用する新規な微生物の提供することにある。The present invention solves the above-mentioned problems, and
An object of the present invention is to provide a novel PHA which is biodegradable and has a phenyl group as a substituent, and a method for producing the above-mentioned PHA having a phenyl group as a substituent using a microorganism. To provide new microorganisms. In particular, a method for producing a novel PHA using 3-hydroxy-6-phenyl-hexanoic acid (3HPHx) as a single monomer unit and a PHA having the phenyl group as a substituent using a microorganism, An object of the present invention is to provide a novel microorganism to be used.
【0014】[0014]
【課題を解決するための手段】本発明者は、前記の課題
を解決すべく、特に、デバイス材料や医用材料等として
有用な、フェニル基を側鎖上に置換基として有する新規
なPHAの開発を目指して、新規なPHAを生産し、菌
体内に蓄積する能力を有する微生物の探索、ならびに、
探索した微生物を用いて、所望のPHAを製造する方法
について、鋭意研究を進めた。その結果、6−フェニル
ヘキサン酸(PHxA)を原料とし、3−ヒドロキシ−
6−フェニル−ヘキサン酸(3HPHx)をモノマーユ
ニットとして含む新規なPHAを生産し菌体内に蓄積す
る能力を有する微生物が存在することを見出し、本発明
を完成するに至った。In order to solve the above-mentioned problems, the present inventors have developed a novel PHA having a phenyl group as a substituent on a side chain, which is particularly useful as a device material or a medical material. In search of microorganisms capable of producing new PHA and accumulating in the cells,
Using the searched microorganisms, the intense research was conducted on a method for producing a desired PHA. As a result, using 6-phenylhexanoic acid (PHxA) as a raw material,
The present inventors have found that there is a microorganism capable of producing and accumulating a novel PHA containing 6-phenyl-hexanoic acid (3HPHx) as a monomer unit and accumulating the same in a microbial cell, and completed the present invention.
【0015】すなわち、本発明が提供する新規なのポリ
ヒドロキシアルカノエートは、化学式(I):That is, the novel polyhydroxyalkanoate provided by the present invention has a chemical formula (I):
【0016】[0016]
【化3】 Embedded image
【0017】で表されるモノマーユニットを含むポリヒ
ドロキシアルカノエートである。A polyhydroxyalkanoate containing a monomer unit represented by the formula:
【0018】また、本発明のポリヒドロキシアルカノエ
ートの製造方法は、化学式(II):Further, the method for producing the polyhydroxyalkanoate of the present invention comprises a process represented by the following chemical formula (II):
【0019】[0019]
【化4】 Embedded image
【0020】で表される6−フェニルヘキサン酸(PH
xA)を含む培地で微生物を培養することを特徴とする
ポリヒドロキシアルカノエートの製造方法である。通
常、微生物を培養したのち、上記化学式(I)で表され
る3−ヒドロキシ−6−フェニルヘキサン酸(3HPH
x)に由来するモノマーユニットを含むポリヒドロキシ
アルカノエートを抽出する工程を設けるとよい。6-phenylhexanoic acid (PH
A method for producing polyhydroxyalkanoate, which comprises culturing a microorganism in a medium containing xA). Usually, after culturing a microorganism, 3-hydroxy-6-phenylhexanoic acid (3HPH) represented by the above chemical formula (I)
A step of extracting a polyhydroxyalkanoate containing a monomer unit derived from x) may be provided.
【0021】なお、利用するPHAを生産し菌体内に蓄
積する能力を有する微生物は、シュードモナス属(Pseu
domonas sp.)に属する菌から選択すると好ましい。例
えば、シュードモナス・ジェッセニイ・P161株(Ps
eudomonas jessenii P161、FERM P−17445)
を利用すると、より好ましい。The microorganism having the ability to produce and accumulate PHA to be used is Pseudomonas sp.
domonas sp.). For example, Pseudomonas jessenii P161 strain (Ps
eudomonas jessenii P161, FERM P-17445)
Is more preferable.
【0022】[0022]
【発明の実施の形態】まず、本発明の製造方法は、6−
フェニルヘキサン酸(PHxA)を原料(基質)として
用いて、3−ヒドロキシ−6−フェニルヘキサン酸(3
HPHx)をモノマーユニットとして含むPHAを生産
し、菌体内に蓄積するという能力を有する微生物を利用
する方法である。このような新規な酵素反応性を示す微
生物は、本発明者らの探索により見出されたものであ
る。その好適な菌株の一例が、P161株であり、本発
明者らが新たに土壌より分離した微生物である。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS First, the production method of the present invention comprises the steps of:
Using phenylhexanoic acid (PHxA) as a raw material (substrate), 3-hydroxy-6-phenylhexanoic acid (3
This is a method that utilizes a microorganism that has the ability to produce PHA containing HPHx) as a monomer unit and accumulate it in cells. A microorganism exhibiting such a novel enzyme reactivity has been found by the present inventors' search. One example of the preferred strain is P161 strain, which is a microorganism newly isolated from the soil by the present inventors.
【0023】 <P161株の菌学的性質>形態学的性質 細胞の形と大きさ :球状、φ0.6μm 桿状、0.6μm×1.5〜2.0μm 細胞の多形性 :あり(伸長型) 運動性 :あり 胞子形成 :なし グラム染色性 :陰性 コロニー形状 :円形、全縁なめらか、低凸状、表層なめらか、 淡黄色生理学的性質 カタラーゼ :陽性 オキシダーゼ :陽性 O/F試験 :酸化型 硝酸塩の還元 :陽性 インドールの生成 :陰性 ブドウ糖酸性化 :陰性 アルギニンジヒドロラーゼ :陽性 ウレアーゼ :陰性 エスクリン加水分解 :陰性 ゼラチン加水分解 :陰性 β−ガラクトシダーゼ :陰性 King'sB寒天での蛍光色素産生 :陽性基質資化能 ブドウ糖 :陽性 L−アラビノース :陽性 D−マンノース :陽性 D−マンニトール :陽性 N−アセチル−D−グルコサミン :陽性 マルトース :陰性 グルコン酸カリウム :陽性 n−カプリン酸 :陽性 アジピン酸 :陰性 dl−リンゴ酸 :陽性 クエン酸ナトリウム :陽性 酢酸フェニル :陽性 以上の菌学的性質から、バージェーズ・マニュアル・オ
ブ・システマティック・バクテリオロジー・第1巻(Be
rgey's Manual of Systematic Bacteriology,Volume1)
(1984年)及びバージェーズ・マニュアル・オブ・
ディタミネーティブ・バクテリオロジー(Bergey' s Ma
nual of Determinative Bacteriology)第9版(199
4年)に基づいて検索したところ、P161株は、シュ
ードモナス属(Pseudomonas sp.)に属すると判明した
ものの、その菌学的性質から分類学上の位置を確定する
には至らなかった。<Mycological properties of strain P161> Morphological properties Shape and size of cells: spherical, φ0.6 μm rod, 0.6 μm × 1.5-2.0 μm Cell polymorphism: yes (elongation) Motility: Yes Sporulation: No Gram stain: Negative Colony shape: Circular, whole edge smooth, low convex, surface smooth, pale yellow physiological properties Catalase: Positive oxidase: Positive O / F test: Oxidized nitrate Reduction: Positive Indole formation: Negative Glucose acidification: Negative Arginine dihydrolase: Positive urease: Negative Esculin hydrolysis: Negative Gelatin hydrolysis: Negative β-galactosidase: Negative Fluorescent dye production on King's B agar: Positive substrate Chemoactive glucose: positive L-arabinose: positive D-mannose: positive D-mannitol: positive N-acetyl-D-glucose Samin: Positive Maltose: Negative Potassium gluconate: Positive n-Capric acid: Positive Adipic acid: Negative dl-Malic acid: Positive Sodium citrate: Positive Phenyl acetate: Positive Systematic Bacteriology Volume 1 (Be
rgey's Manual of Systematic Bacteriology, Volume1)
(1984) and the Burgess Manual of
Deterministic bacteriology (Bergey's Ma
nual of Determinative Bacteriology) 9th edition (199
The P161 strain was found to belong to the genus Pseudomonas (Pseudomonas sp.), However, the taxonomic position could not be determined from its mycological properties.
【0024】そこで、遺伝的性質からの分類を試みるた
めに、P161株の16S rRNAの塩基配列を決定
し(配列番号:1、cDNA to rRNA)、公知のシュードモ
ナス属微生物の16S rRNAの塩基配列との相同性
を調べた。P161株とシュードモナス・ジェッセニイ
(Pseudomonas jessenii)との間で、塩基配列の相同性
が極めて高いことが判明した。さらに、System. Appl.
Microbiol., 20, 137-149 (1997)、及び、System. App
l. Microbiol., 22, 45-58 (1999)に記載されたシュー
ドモナス・ジェッセニイの菌学的性質と、P161株の
菌学的性質との間で高い類似性も認められた。以上の結
果から、P161株はシュードモナス・ジェッセニイに
属せしめるのが妥当と判断されたため、P161株をシ
ュードモナス・ジェッセニイ・P161株と命名した。
なお、シュードモナス・ジェッセニイ・P161株は寄
託番号「FERM P−17445」として、通商産業
省工業技術院 生命工学工業技術研究所(特許微生物寄
託センター)に寄託されている。Therefore, in order to try classification based on genetic properties, the nucleotide sequence of 16S rRNA of the P161 strain was determined (SEQ ID NO: 1, cDNA to rRNA), and the nucleotide sequence of 16S rRNA of the known microorganism of the genus Pseudomonas was determined. Were examined for homology. It has been found that the nucleotide sequence homology between the P161 strain and Pseudomonas jessenii is extremely high. In addition, System.Appl.
Microbiol., 20, 137-149 (1997) and System.App
High similarity was also observed between the mycological properties of Pseudomonas gessenii described in l. Microbiol., 22, 45-58 (1999) and the mycological properties of strain P161. Based on the above results, it was determined that the P161 strain belonged to Pseudomonas jessenii. Therefore, the P161 strain was named Pseudomonas jessenii P161.
The Pseudomonas jessenii P161 strain has been deposited with the Ministry of International Trade and Industry, National Institute of Advanced Industrial Science and Technology, Biotechnology and Industrial Technology Research Institute (Patent Microorganisms Depositary Center) under the deposit number "FERM P-17445".
【0025】本発明のポリヒドロキシアルカノエートの
製造方法においては、前記P161株など、シュードモ
ナス属に属し、6−フェニルヘキサン酸(PHxA)を
原料(基質)として、3−ヒドロキシ−6−フェニルヘ
キサン酸(3HPHx)に変換し、PHAを生産する微
生物を用いると好ましい。また、シュードモナス属に属
する微生物に加えて、アエロモナス(Aeromonas sp.)
属、コマモナス(Comamonas sp.)属、バークホルデリ
ア(Burkholderia sp.)属などに属し、6−フェニルヘ
キサン酸(PHxA)を原料(基質)として用いて、3
−ヒドロキシ−6−フェニルヘキサン酸(3HPHx)
をモノマーユニットとして含むPHAを生産する微生物
を用いることも可能である。In the method for producing a polyhydroxyalkanoate of the present invention, 3-hydroxy-6-phenylhexanoic acid belonging to the genus Pseudomonas, such as the above-mentioned strain P161, is prepared by using 6-phenylhexanoic acid (PHxA) as a raw material (substrate). It is preferable to use a microorganism that converts to (3HPHx) and produces PHA. In addition to microorganisms belonging to the genus Pseudomonas, Aeromonas (Aeromonas sp.)
Genus, Comamonas sp., Burkholderia sp., Etc., and using 6-phenylhexanoic acid (PHxA) as a raw material (substrate).
-Hydroxy-6-phenylhexanoic acid (3HPHx)
It is also possible to use a microorganism that produces PHA containing as a monomer unit.
【0026】本発明に利用する微生物を通常増殖させる
場合は、微生物の生育や生存に悪影響を及ぼすものでな
い限り、一般的な天然培地(肉汁培地等)や栄養源を添
加した合成培地等、いかなる種類の培地をも用いること
ができる。When the microorganism used in the present invention is usually grown, any natural medium (such as a broth medium) or a synthetic medium to which nutrients are added, as long as it does not adversely affect the growth and survival of the microorganism, may be used. Different types of media can also be used.
【0027】本発明に利用する微生物は、3HPHxに
由来する化学式(I):The microorganism used in the present invention has a chemical formula (I) derived from 3HPHx:
【0028】[0028]
【化5】 Embedded image
【0029】で表されるモノマーユニットを含むPHA
を生産・蓄積させる能力を具えており、他のモノマーユ
ニットを含むPHAが混在してもよい場合は、増殖用炭
素源としてオクタン酸やノナン酸等の中鎖の脂肪酸と、
PHxAとを含んだ無機培地等で対数増殖後期から定常
期の時点まで培養し、菌体を遠心分離等で回収したの
ち、中鎖の脂肪酸とPVAとを含んだ、窒素源が存在し
ない無機培地で更に培養する方法を用いることができ
る。あるいは、無機塩培地中の窒素源濃度を1/10程
度に制限し、中鎖の脂肪酸とPHxAとを与えて培養
し、対数増殖後期から定常期の時点で菌体を回収して所
望のPHAを抽出する方法を用いることもできる。これ
ら増殖用炭素源として、中鎖の脂肪酸を培地に添加する
方法では、取得されるPHAは、増殖用炭素源として添
加した中鎖の脂肪酸に由来するモノマーユニットが混在
しているPHAとなっている。PHA containing a monomer unit represented by the following formula:
If it has the ability to produce and accumulate, PHA containing other monomer units may be mixed, medium-chain fatty acids such as octanoic acid and nonanoic acid as a carbon source for growth,
After culturing from the late logarithmic growth phase to the stationary phase in an inorganic medium or the like containing PHxA and collecting cells by centrifugation or the like, an inorganic medium containing a medium-chain fatty acid and PVA and containing no nitrogen source is used. And a method of further culturing. Alternatively, the concentration of the nitrogen source in the inorganic salt medium is restricted to about 1/10, and medium-chain fatty acids and PHxA are fed and cultured. Can be used. In the method of adding a medium-chain fatty acid as a carbon source for growth to a medium, the obtained PHA becomes PHA in which monomer units derived from the medium-chain fatty acid added as a carbon source for growth are mixed. I have.
【0030】本発明のPHPHxの製造方法は、微生物
を用いて、PHPHxのみを選択的に生産・蓄積させる
際には、酵母エキスとPHxAとを含む培地で微生物を
培養すると好ましい。例えば、培地に、酵母エキスを
0.1%から1.0%程度、及び、PHxAを0.01
%から0.5%程度含んだ無機培地等を用いて、対数増
殖後期から定常期の時点まで微生物を培養し、菌体を遠
心分離等で回収した後、PHxAを0.01%から0.
5%程度を含んだ、窒素源が存在しない無機培地で更に
培養する二段階の培養方法をとることができる。また、
酵母エキスを0.1%から1.0%程度、及び、PHx
Aを0.01%から0.5%程度含んだ無機培地で培養
し、対数増殖後期から定常期の時点で菌体を回収して、
菌体から所望のPHAを抽出する一段階の培養方法とす
ることもできる。In the method of producing PHPHx of the present invention, when selectively producing and accumulating only PHPHx using a microorganism, it is preferable to culture the microorganism in a medium containing a yeast extract and PHxA. For example, about 0.1% to 1.0% of yeast extract and 0.01% of PHxA are added to a medium.
The microorganism is cultured from the late logarithmic growth phase to the stationary phase using an inorganic medium or the like containing about 0.5% to 0.5%, and the cells are collected by centrifugation or the like.
A two-stage culturing method can be employed in which culturing is further performed in an inorganic medium containing no nitrogen source and containing about 5%. Also,
About 0.1% to 1.0% of yeast extract and PHx
A is cultivated in an inorganic medium containing about 0.01% to 0.5% of A, and the cells are collected from the late logarithmic phase to the stationary phase,
It is also possible to use a one-stage culture method for extracting a desired PHA from the cells.
【0031】前記の培養方法において、培地の調製に用
いる無機培地は、リン源(例えば、リン酸塩等)、窒素
源(例えば、アンモニウム塩、硝酸塩等)等、微生物が
増殖し得る成分を含んでいるものであればいかなるもの
でも良く、例えば、MSB培地、M9培地等を挙げるこ
とができる。なお、後述する本発明の具体例である、実
施例において用いるM9培地の組成は以下の通りであ
る。Na2HPO4:6.2 g、KH2PO4:3.0
g、NaCl:0.5 g、NH4Cl:1.0 g(培
地1リットル中、pH7.0)。In the above-mentioned culturing method, the inorganic medium used for preparing the medium contains components such as a phosphorus source (for example, phosphate) and a nitrogen source (for example, ammonium salt, nitrate, etc.) that can be proliferated by microorganisms. Any medium may be used as long as it is suitable for use, and examples thereof include an MSB medium and an M9 medium. The composition of the M9 medium used in Examples, which is a specific example of the present invention described below, is as follows. Na 2 HPO 4 : 6.2 g, KH 2 PO 4 : 3.0
g, NaCl: 0.5 g, NH 4 Cl: 1.0 g (in 1 liter of medium, pH 7.0).
【0032】また、培地に添加する原料のPHxAの濃
度は、微生物の属種、菌体密度、あるいは培養方法に応
じて適宜選択するものであるが、通常、培地中の含有率
を0.01%から0.5%程度に選択して、添加すると
よい。加えて、培地に酵母エキスを同時に添加すると好
ましく、その際、添加する酵母エキス濃度は、微生物の
属種、菌体密度、あるいは培養方法に応じて適宜選択す
るものであるが、通常、培地中の含有率を0.1%から
1.0%程度に選択して、添加するとよい。The concentration of PHxA as a raw material to be added to the medium is appropriately selected depending on the genus of the microorganism, the cell density, or the culturing method. % To about 0.5%. In addition, it is preferable to add yeast extract to the medium at the same time.At this time, the concentration of the yeast extract to be added is appropriately selected depending on the genus of the microorganism, the cell density, or the culture method. Is selected from about 0.1% to about 1.0% and added.
【0033】また、上記の培養方法は、バッチ式、流動
バッチ式、連続培養、リアクター形式等、通常の微生物
の培養に用いるいかなる方法をも用いることができる。
その際、培養温度は、利用する微生物が生育・増殖が可
能な温度範囲、例えば、20℃〜30℃程度に維持する
とよい。As the above-mentioned culturing method, any method used for ordinary culturing of microorganisms, such as a batch type, a flow batch type, a continuous culturing, a reactor type, etc., can be used.
At this time, the culture temperature is preferably maintained in a temperature range in which the microorganism to be used can grow and proliferate, for example, about 20 ° C to 30 ° C.
【0034】本発明の製造方法においては、培養菌体か
らのPHAの回収は、通常行われているクロロホルム等
の有機溶媒による抽出が最も簡便である。この有機溶媒
を用いる抽出法以外にも、有機溶媒を用いず、例えば、
SDS等の界面活性剤処理、リゾチーム等の酵素処理、
EDTA、次亜塩素酸ナトリウム、アンモニア等の薬剤
処理によってPHA以外の菌体内成分を除去することに
よって、PHAのみを回収する方法を採ることもでき
る。In the production method of the present invention, the simplest method of recovering PHA from cultured cells is the usual extraction with an organic solvent such as chloroform. Other than the extraction method using this organic solvent, without using an organic solvent, for example,
Surfactant treatment such as SDS, enzyme treatment such as lysozyme,
It is also possible to adopt a method of recovering only PHA by removing intracellular components other than PHA by treatment with a chemical such as EDTA, sodium hypochlorite, and ammonia.
【0035】なお、本発明において、微生物の培養、微
生物によるPHAの生産と菌体内への蓄積、並びに、菌
体からのPHAの回収は、上に例示した具体的な方法に
限定されるものではない。In the present invention, the cultivation of microorganisms, production of PHA by microorganisms, accumulation in microorganisms, and recovery of PHA from microorganisms are not limited to the specific methods exemplified above. Absent.
【0036】[0036]
【実施例】以下に、具体例を示し、本発明の製造方法を
より詳しく説明する。これらの具体例は、本発明におけ
る最良の態様の一例であるが、本発明は以下の具体例に
よってなんら限定されるものではない。The present invention will be described in more detail with reference to specific examples. These specific examples are examples of the best mode of the present invention, but the present invention is not limited by the following specific examples.
【0037】(実施例1)酵母エキス0.1%、PHx
A0.1%を含むM9培地200mlにP161株を植
菌し、30℃、125ストローク/分で振盪培養した。
24時間後、菌体を遠心分離によって回収し、PHxA
0.1%を含む、窒素源(NH4Cl)を含まないM9
培地200mlに再懸濁して、更に30℃、125スト
ローク/分で振盪培養した。24時間後、菌体を遠心分
離によって回収し、冷メタノールで一度洗浄して凍結乾
燥した。Example 1 0.1% yeast extract, PHx
The P161 strain was inoculated into 200 ml of M9 medium containing 0.1% of A, and cultured with shaking at 30 ° C. and 125 strokes / min.
After 24 hours, the cells were collected by centrifugation, and PHxA
M9 without 0.1% nitrogen source (NH 4 Cl)
The cells were resuspended in 200 ml of the medium, and cultured with shaking at 30 ° C. and 125 strokes / min. After 24 hours, the cells were collected by centrifugation, washed once with cold methanol and freeze-dried.
【0038】この凍結乾燥ペレットを100mlのクロ
ロホルムに懸濁し、60℃で20時間攪拌してPHAを
抽出した。抽出液を孔径0.45μmのメンブレンフィ
ルターでろ過したのち、ロータリーエバポレーターで濃
縮し、濃縮液を冷メタノール中で再沈殿させ、更に沈殿
のみを回収して真空乾燥してPHAを得た。The lyophilized pellet was suspended in 100 ml of chloroform and stirred at 60 ° C. for 20 hours to extract PHA. After the extract was filtered with a membrane filter having a pore size of 0.45 μm, the extract was concentrated with a rotary evaporator, the concentrate was reprecipitated in cold methanol, and only the precipitate was recovered and dried in vacuo to obtain PHA.
【0039】上記のPHA100mgをクロロホルム1
mlに溶解し、次にノルマルヘキサンを白濁するまで添
加した。これを遠心分離して沈殿部分を回収し、真空乾
燥した。これを再びクロロホルム1mlに溶解し、ノル
マルヘキサンを添加し、沈殿部分を回収する操作を3回
繰返して行った。The above PHA (100 mg) was mixed with chloroform (1).
and then added normal hexane until cloudy. This was centrifuged to collect a precipitate, and dried under vacuum. The operation of dissolving this in 1 ml of chloroform again, adding normal hexane, and collecting the precipitated portion was repeated three times.
【0040】得られた沈殿部分は、常法に従ってメタノ
リシスを行ったのち、ガスクロマトグラフィー−質量分
析装置(GC−MS,島津QP−5050、EI法)で
分析し、PHAモノマーユニットのメチルエステル化物
の同定を行った。また、このPHAの分子量を、ゲルパ
ーミエーションクロマトグラフィー(GPC;東ソー・
HLC−8020、カラム;ポリマーラボラトリー・P
Lgel・MIXED−C・5μm、溶媒;クロロホル
ム、ポリスチレン換算分子量)により測定した。表1
に、同定結果、平均分子量、ならびに凍結乾燥ペレッ
ト、回収ポリマーの収量、収率を示す。その結果、表1
に示す通り、3HPHxのみをモノマーユニットとする
PHAであることが確認された。The obtained precipitate was subjected to methanolysis according to a conventional method, and then analyzed by a gas chromatography-mass spectrometer (GC-MS, Shimadzu QP-5050, EI method) to obtain a methyl ester of a PHA monomer unit. Was identified. The molecular weight of the PHA was determined by gel permeation chromatography (GPC; Tosoh Corporation).
HLC-8020, column; Polymer Laboratory P
Lgel MIXED-C 5 μm, solvent; chloroform, molecular weight in terms of polystyrene). Table 1
Table 2 shows the identification results, the average molecular weight, and the yields and yields of the lyophilized pellets and the recovered polymer. As a result, Table 1
As shown in the figure, it was confirmed that the PHA was a monomer unit containing only 3HPHx as a monomer unit.
【0041】[0041]
【表1】 [Table 1]
【0042】このPHAについて、核磁気共鳴装置(F
T−NMR:Bruker DPX400)を用いて、
以下の条件で分析した。測定核種:1H、使用溶媒:重
クロロホルム(TMS入り)。図1に、1H−NMRス
ペクトル測定結果、表2にその帰属を示す。This PHA is prepared by a nuclear magnetic resonance apparatus (F
T-NMR: using Bruker DPX400)
The analysis was performed under the following conditions. Measurement nuclide: 1 H, Solvent used: deuterated chloroform (containing TMS). FIG. 1 shows the 1 H-NMR spectrum measurement results and Table 2 shows the assignment.
【0043】[0043]
【表2】 [Table 2]
【0044】本実施例のように、酵母エキスと原料の6
−フェニルヘキサン酸を添加した無機培地で培養する
と、菌体内に蓄積されるPHAは、3HPHxのみをモ
ノマーユニットとするPHAであることが、この表2に
示す測定結果からも確認される。As in this example, the yeast extract and the raw material 6
It is also confirmed from the measurement results shown in Table 2 that when cultured in an inorganic medium supplemented with -phenylhexanoic acid, the PHA accumulated in the cells is a PHA containing only 3HPHx as a monomer unit.
【0045】[0045]
【発明の効果】本発明の製造方法により、微生物産生ポ
リヒドロキシアルカノエートの一種である、3−ヒドロ
キシ−6−フェニルヘキサン酸をモノマーユニットとし
て含む新規ポリヒドロキシアルカノエートの選択的な生
産が可能となる。加えて、この3−ヒドロキシ−6−フ
ェニルヘキサン酸をモノマーユニットとして含む新規ポ
リヒドロキシアルカノエートは、例えば、P161株な
どを利用して効率的に製造できる。機能性ポリマーとし
ても有用であり、特に、そのホモポリマーは、デバイス
材料や医用材料等の各分野への応用が期待できる。Industrial Applicability According to the production method of the present invention, it is possible to selectively produce a novel polyhydroxyalkanoate containing 3-hydroxy-6-phenylhexanoic acid as a monomer unit, which is a kind of polyhydroxyalkanoate produced by microorganisms. Become. In addition, the novel polyhydroxyalkanoate containing 3-hydroxy-6-phenylhexanoic acid as a monomer unit can be efficiently produced using, for example, strain P161. It is also useful as a functional polymer, and in particular, its homopolymer can be expected to be applied to various fields such as device materials and medical materials.
【0046】[0046]
【配列表】 SEQUENCE LISTING <110> CANON INC. <120> Preparation of Poly-hidroxyalkanoic Acid <130> 4052004 <160> 1 <170> Microsoft Word <210> 1 <211> 1501 <212> DNA <213> Pseudomonas jessenii P161 ; FERM P-17445 <400> 1 tgaacgctgg cggcaggcct aacacatgca agtcgagcgg 40 atgacgggag cttgctcctg aattcagcgg cggacgggtg 80 agtaatgcct aggaatctgc ctggtagtgg gggacaacgt 120 ctcgaaaggg acgctaatac cgcatacgtc ctacgggaga 160 aagcagggga ccttcgggcc ttgcgctatc agatgagcct 200 aggtcggatt agctagttgg tgaggtaatg gctcaccaag 240 gcgacgatcc gtaactggtc tgagaggatg atcagtcaca 280 ctggaactga gacacggtcc agactcctac gggaggcagc 320 agtggggaat attggacaat gggcgaaagc ctgatccagc 360 catgccgcgt gtgtgaagaa ggtcttcgga ttgtaaagca 400 ctttaagttg ggaggaaggg cattaaccta atacgttagt 440 gttttgacgt taccgacaga ataagcaccg gctaactctg 480 tgccagcagc cgcggtaata cagagggtgc aagcgttaat 520 cggaattact gggcgtaaag cgcgcgtagg tggtttgtta 560 agttggatgt gaaagccccg ggctcaacct gggaactgca 600 ttcaaaactg acaagctaga gtatggtaga gggtggtgga 640 atttcctgtg tagcggtgaa atgcgtagat ataggaagga 680 acaccagtgg cgaaggcgac cacctggact gatactgaca 720 ctgaggtgcg aaagcgtggg gagcaaacag gattagatac 760 cctggtagtc cacgccgtaa acgatgtcaa ctagccgttg 800 ggagccttga gctcttagtg gcgcagctaa cgcattaagt 840 tgaccgcctg gggagtacgg ccgcaaggtt aaaactcaaa 880 tgaattgacg ggggcccgca caagcggtgg agcatgtggt 920 ttaattcgaa gcaacgcgaa gaaccttacc aggccttgac 960 atccaatgaa ctttccagag atggatgggt gccttcggga 1000 acattgagac aggtgctgca tggctgtcgt cagctcgtgt 1040 cgtgagatgt tgggttaagt cccgtaacga gcgcaaccct 1080 tgtccttagt taccagcacg taatggtggg cactctaagg 1120 agactgccgg tgacaaaccg gaggaaggtg gggatgacgt 1160 caagtcatca tggcccttac ggcctgggct acacacgtgc 1200 tacaatggtc ggtacagagg gttgccaagc cgcgaggtgg 1240 agctaatccc acaaaaccga tcgtagtccg gatcgcagtc 1280 tgcaactcga ctgcgtgaag tcggaatcgc tagtaatcgc 1320 gaatcagaat gtcgcggtga atacgttccc gggccttgta 1360 cacaccgccc gtcacaccat gggagtgggt tgcaccagaa 1400 gtagctagtc taaccttcgg gaggacggtt accacggtgt 1440 gattcatgac tggggtgaag tcgtaccaag gtagccgtag 1480 gggaacctgc ggctggatca c 1501[Sequence List] SEQUENCE LISTING <110> CANON INC. <120> Preparation of Poly-hidroxyalkanoic Acid <130> 4052004 <160> 1 <170> Microsoft Word <210> 1 <211> 1501 <212> DNA <213> Pseudomonas jessenii P161; FERM P-17445 <400> 1 tgaacgctgg cggcaggcct aacacatgca agtcgagcgg 40 atgacgggag cttgctcctg aattcagcgg cggacgggtg 80 agtaatgcct aggaatctgc ctggtagtgg gggacaacgt 120 ctcgaaaggg acgctaatac cgcatacgtc ctacgggaga 160 aagcagggga ccttcgggcc ttgcgctatc agatgagcct 200 aggtcggatt agctagttgg tgaggtaatg gctcaccaag 240 gcgacgatcc gtaactggtc tgagaggatg atcagtcaca 280 ctggaactga gacacggtcc agactcctac gggaggcagc 320 agtggggaat attggacaat gggcgaaagc ctgatccagc 360 catgccgcgt gtgtgaagaa ggtcttcgga ttgtaaagca 400 ctttaagttg ggaggaaggg cattaaccta atacgttagt 440 gttttgacgt taccgacaga ataagcaccg gctaactctg 480 tgccagcagc cgcggtaata cagagggtgc aagcgttaat 520 cggaattact gggcgtaaag cgcgcgtagg tggtttgtta 560 agttggatgt gaaagccccg ggctcaacct gggaactgca 600 ttcaaaactg acaagctaga gtatggtaga gggtggtgga 640 atttcctgtg tagcggtgaa atgcgtagat ataggaagga 680 acaccagtgg cgaaggcgac cacctggact gatactgaca 720 ctgaggtgcg aaagcgtggg gagcaaacag gattagatac 760 cctggtagtc cacgccgtaa acgatgtcaa ctagccgttg 800 ggagccttga gctcttagtg gcgcagctaa cgcattaagt 840 tgaccgcctg gggagtacgg ccgcaaggtt aaaactcaaa 880 tgaattgacg ggggcccgca caagcggtgg agcatgtggt 920 ttaattcgaa gcaacgcgaa gaaccttacc aggccttgac 960 atccaatgaa ctttccagag atggatgggt gccttcggga 1000 acattgagac aggtgctgca tggctgtcgt cagctcgtgt 1040 cgtgagatgt tgggttaagt cccgtaacga gcgcaaccct 1080 tgtccttagt taccagcacg taatggtggg cactctaagg 1120 agactgccgg tgacaaaccg gaggaaggtg gggatgacgt 1160 caagtcatca tggcccttac ggcctgggct acacacgtgc 1200 tacaatggtc ggtacagagg gttgccaagc cgcgaggtgg 1240 agctaatccc acaaaaccga tcgtagtccg gatcgcagtc 1280 tgcaactcga ctgcgtgaag tcggaatcgc tagtaatcgc 1320 gaatcagaat gtcgcggtga atacgttccc gggccttgta 1360 cacaccgccc gtcacaccat gggagtgggt tgcaccagaa 1400 gtagctagtc taaccttcgg gaggacggtt accacggtgt 1440 gattcatgac tggggtgaag tcgtaccaag gtagc cgtag 1480 gggaacctgc ggctggatca c 1501
【図1】本発明の製造方法によって、P161株により
産生されたポリ−3−ヒドロキシ−6−フェニルヘキサ
ン酸の1H−NMRスペクトル測定結果を示す。FIG. 1 shows the 1 H-NMR spectrum measurement results of poly-3-hydroxy-6-phenylhexanoic acid produced by strain P161 by the production method of the present invention.
【図2】シュードモナス ジェッセニイ P161株(Ps
eudomonas jessenii P161;FERM P−17445)
の16S rRNAの塩基配列を示す。FIG. 2: Pseudomonas jesseny P161 strain (Ps
eudomonas jessenii P161; FERM P-17445)
1 shows the nucleotide sequence of 16S rRNA.
フロントページの続き (72)発明者 矢野 哲哉 東京都大田区下丸子3丁目30番2号 キヤ ノン株式会社内 (72)発明者 須田 栄 東京都大田区下丸子3丁目30番2号 キヤ ノン株式会社内 (72)発明者 小林 辰 東京都大田区下丸子3丁目30番2号 キヤ ノン株式会社内 Fターム(参考) 4B064 AD83 CA02 CC03 CD07 DA16 4J029 AA02 AB04 AC01 AE06 EB01Continued on the front page (72) Inventor Tetsuya Yano 3-30-2 Shimomaruko, Ota-ku, Tokyo Inside Canon Inc. (72) Inventor Sakae 3-30-2 Shimomaruko, Ota-ku, Tokyo Inside Canon Inc. (72) Inventor Tatsu Kobayashi F-term (reference) 4B064 AD83 CA02 CC03 CD07 DA16 4J029 AA02 AB04 AC01 AE06 EB01, 3-30-2 Shimomaruko, Ota-ku, Tokyo
Claims (1)
カノエートの製造方法であって、 化学式(II): 【化2】 で表される6−フェニルヘキサン酸を含む培地でシュー
ドモナス・ジェッセニイ・P161株(Pseudomonas je
ssenii P161、FERM P−17445)を培養するこ
とを特徴とするポリヒドロキシアルカノエートの製造方
法。[Claim 1] Chemical formula (I): A method for producing a polyhydroxyalkanoate containing a monomer unit represented by the following formula: In a medium containing 6-phenylhexanoic acid represented by the following formula, Pseudomonas jessenii P161 strain (Pseudomonas je
ssenii P161, FERM P-17445), which comprises culturing the polyhydroxyalkanoate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP37187099A JP2001178486A (en) | 1999-12-27 | 1999-12-27 | Method for producing polyhydroxyalkanoate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP37187099A JP2001178486A (en) | 1999-12-27 | 1999-12-27 | Method for producing polyhydroxyalkanoate |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001178486A true JP2001178486A (en) | 2001-07-03 |
JP2001178486A5 JP2001178486A5 (en) | 2004-11-25 |
Family
ID=18499449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP37187099A Withdrawn JP2001178486A (en) | 1999-12-27 | 1999-12-27 | Method for producing polyhydroxyalkanoate |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2001178486A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100486475B1 (en) * | 2002-02-15 | 2005-05-03 | 캐논 가부시끼가이샤 | Novel polyhydroxyalkanoate having amide group and sulfonic group, method of producing the same, charge controlling agent containing novel polyhydroxyalkanoate, toner binder, toner, and image formation method and image forming apparatus using the toner |
KR100522483B1 (en) * | 2001-03-01 | 2005-10-18 | 캐논 가부시끼가이샤 | Novel polyhydroxyalkanoate containing unit with phenylsulfanyl structure in the side chain, process for its production, charge control agent, toner binder and toner which contain novel polyhydroxyalkanoate, and image-forming method and image-forming apparatus which make use of the toner |
-
1999
- 1999-12-27 JP JP37187099A patent/JP2001178486A/en not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100522483B1 (en) * | 2001-03-01 | 2005-10-18 | 캐논 가부시끼가이샤 | Novel polyhydroxyalkanoate containing unit with phenylsulfanyl structure in the side chain, process for its production, charge control agent, toner binder and toner which contain novel polyhydroxyalkanoate, and image-forming method and image-forming apparatus which make use of the toner |
KR100486475B1 (en) * | 2002-02-15 | 2005-05-03 | 캐논 가부시끼가이샤 | Novel polyhydroxyalkanoate having amide group and sulfonic group, method of producing the same, charge controlling agent containing novel polyhydroxyalkanoate, toner binder, toner, and image formation method and image forming apparatus using the toner |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6521429B2 (en) | Polyhydroxyalkanoates and method of producing them by utilizing microorganisms | |
US6803444B2 (en) | Polyhydroxyalkanoate polyester having vinyl phenyl structure in the side chain and its production method | |
JP3684150B2 (en) | Polyhydroxyalkanoate | |
KR100498221B1 (en) | Novel polyhydroxyalkanoate that comprises unit having (methylsulfanyl)phenoxy structure in side chain thereof and process for producing the same | |
KR100487877B1 (en) | Polyhydroxyalkanoate containing 3-hydroxybenzoylalkanoic acid as monomer unit and method for producing the same | |
JP3768799B2 (en) | Process for producing polyhydroxyalkanoate from substituted fatty acid ester | |
EP1367078B1 (en) | Method of producing polyhydroxyalkanoate from alkane having residue containing aromatic ring in its molecule | |
JP2004196832A (en) | New polyhydroxyalkanoate copolymer containing unit with brominated side chain and production method therefor | |
JP2001178484A (en) | Method for producing polyhydroxyalkanoic acid | |
JP2001178486A (en) | Method for producing polyhydroxyalkanoate | |
JP3880473B2 (en) | NOVEL POLYHYDROXYALKANOATES CONTAINING UNITS HAVING (METHYLSULFANYL) PHENOXY STRUCTURES IN SIDE CHAIN | |
JP2001316462A (en) | Polyhydroxy alkanoate containing 3-hydroxythienyl alkanoic acid as monomer unit and manufacturing method thereof | |
JP2004162045A (en) | New polyhydroxyalkanoate containing unit bearing (phenylmethyl)oxy structure in side chain, and its manufacturing method | |
JP4147225B2 (en) | Polyhydroxyalkanoate and its production method using microorganism | |
JP2002125655A (en) | Apparatus for producing polyhydroxyalkanoate | |
JP2001178485A (en) | Method for producing polyhydroxyalkanoate | |
JP4812061B2 (en) | Novel polyhydroxyalkanoate containing unit having [(substituted phenyl) methyl] sulfanyl structure in side chain and method for producing the same | |
JP2001238669A (en) | Microorganism producing polyhydroxyalkanoate and method for producing polyhydroxyalkanoate using the microorganism | |
JP2003089720A (en) | New polyhydroxyalkanoate containing unit having (phenylmethyl)sulfanyl structure in side chain, and method for producing the same | |
JP2002173521A (en) | Polyhydroxyalkanoate containing 3-hydroxy- benzoylalkanoic acid as monomer unit and method for manufacturing the same | |
JP2002256066A (en) | New polyhydroxyalknoate containing 3-hydroxy-5-(4- cyanophenoxy)valeric unit, and production method thereof | |
JP2001238668A (en) | Microorganism producing poly-3-hydroxy-4-phenoxy-n- butyric acid and preparation method for poly-3- hydroxy-4-phenoxy-nbutyric acid using the microorganism | |
JP2002256064A (en) | New polyhydroxyalknoate containing 3-hydroxy-5- phenoxyvaleric unit and 3-hydroxy-5-(4-cyanophenoxy) valeric unit, and production method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20031210 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20031210 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20031210 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060606 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20060802 |